BR0303322A - Galectina de carrapato - Google Patents

Galectina de carrapato

Info

Publication number
BR0303322A
BR0303322A BR0303322-8A BR0303322A BR0303322A BR 0303322 A BR0303322 A BR 0303322A BR 0303322 A BR0303322 A BR 0303322A BR 0303322 A BR0303322 A BR 0303322A
Authority
BR
Brazil
Prior art keywords
galectin
tick
polynucleotide
vector
fever
Prior art date
Application number
BR0303322-8A
Other languages
English (en)
Inventor
Kozo Fujisaki
Hideyuki Nagasawa
Ikuo Igarashi
Hiroshi Suzuki
Chihiro Sugimoto
Gakunan Gen
Kimie Kadota
Noboru Inoue
Naoaki Yokoyama
Naotoshi Tsuji
Original Assignee
Meiji Seika Kaisha
Kozo Fujisaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha, Kozo Fujisaki filed Critical Meiji Seika Kaisha
Publication of BR0303322A publication Critical patent/BR0303322A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

"GALECTINA DE CARRAPATO". A presente invenção refere-se a uma nova galectina, um polinucleotídeo codificando a mesma, um vetor e transformante compreendendo o polinucleotídeo, um anticorpo contra a galectina e um processo de classificação para classificar a substância capaz de modificar a galectina que são descritos. De acordo com a galectina, polinucleotídeo ou vetor, é possível, por exemplo, exterminar carrapatos, tratar ou prevenir infecções transmitidas pelos carrapatos, tais como, rickettsiose, filariose, febre Q, febre recorrente Africana ou encefalite virótica.
BR0303322-8A 2002-02-28 2003-02-28 Galectina de carrapato BR0303322A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002053146 2002-02-28
PCT/JP2003/002336 WO2003072781A1 (fr) 2002-02-28 2003-02-28 Galectine anti-acarienne

Publications (1)

Publication Number Publication Date
BR0303322A true BR0303322A (pt) 2004-12-28

Family

ID=27764351

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0303322-8A BR0303322A (pt) 2002-02-28 2003-02-28 Galectina de carrapato

Country Status (9)

Country Link
US (3) US7135552B2 (pt)
EP (1) EP1479773B8 (pt)
JP (1) JP4300117B2 (pt)
AT (1) ATE338125T1 (pt)
AU (1) AU2003211361B8 (pt)
BR (1) BR0303322A (pt)
DE (1) DE60307987T8 (pt)
NZ (1) NZ535468A (pt)
WO (1) WO2003072781A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60307987T8 (de) * 2002-02-28 2007-05-03 Meiji Seika Kaisha Ltd. Galectin aus milben
JP4719527B2 (ja) * 2005-08-03 2011-07-06 独立行政法人農業・食品産業技術総合研究機構 ベクターマダニのガレクチン、それをコードする核酸分子及びそれらの利用
US20120328568A1 (en) 2010-02-12 2012-12-27 Emory University Compositions and uses of lectins
JP2012059906A (ja) * 2010-09-09 2012-03-22 Sony Corp 記憶素子、メモリ装置
FR3051192B1 (fr) * 2016-05-13 2020-12-25 Univ De Lorraine Methode de purification de proteines recombinantes par affinite basee sur l'activite lectinique du domaine crd d'une galectine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60307987T8 (de) * 2002-02-28 2007-05-03 Meiji Seika Kaisha Ltd. Galectin aus milben
EP1479697A4 (en) 2002-02-28 2007-05-23 Meiji Seika Kaisha TICKS chitinase

Also Published As

Publication number Publication date
EP1479773B1 (en) 2006-08-30
DE60307987T2 (de) 2006-12-21
US8057801B2 (en) 2011-11-15
AU2003211361A1 (en) 2003-09-09
JPWO2003072781A1 (ja) 2005-06-23
EP1479773B8 (en) 2007-02-14
JP4300117B2 (ja) 2009-07-22
AU2003211361B2 (en) 2007-12-13
EP1479773A1 (en) 2004-11-24
US20050106677A1 (en) 2005-05-19
NZ535468A (en) 2006-08-31
EP1479773A4 (en) 2005-07-27
US7547682B2 (en) 2009-06-16
WO2003072781A1 (fr) 2003-09-04
ATE338125T1 (de) 2006-09-15
US20100196407A1 (en) 2010-08-05
AU2003211361B8 (en) 2008-04-03
DE60307987T8 (de) 2007-05-03
US20070021596A1 (en) 2007-01-25
US7135552B2 (en) 2006-11-14
DE60307987D1 (de) 2006-10-12

Similar Documents

Publication Publication Date Title
DK1934353T3 (da) IL-15R alpha sushi domæner som en selektiv og effektiv forstærker af IL-15-virkningen gennem IL-15Rbeta/gamma, i hyperagonist IL-15 Ralpha sushi -IL 15 fusionsproteiner
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
BR0113637A (pt) Composto, processo para a preparação desse composto, composição farmacêutica que compreende o mesmo, utilização do composto, processo para o tratamento e/ou profilaxia de enfermidade que estão associadas com a atividade de receptor melanocortin-4
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
MXPA05012606A (es) Fosforamidatos de nucleosidos como agentes anticancerigenos.
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
DE602005013648D1 (de) Behandlung von bakteriellen infektionen
BR0313491A (pt) composições e métodos para tratar distúrbios associados ao rage
ATE399872T1 (de) Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR0303322A (pt) Galectina de carrapato
BR0116319A (pt) Composição herbicida
BRPI0509667B8 (pt) composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto
UA94716C2 (ru) Кальциепептидный компонент для снижения веса тела
BR0009705A (pt) Inibidores da corrosão resistentes a halogênio
BR0303321A (pt) Quitinase de carrapato
BR9805585A (pt) Estabilização de misturas de policarbonato/abs com misturas de aminas impedidas e absorventes de uv.
AU2003251729A8 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
MXPA04003528A (es) Mimeticos de rankl y usos de los mismos.
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
EP1620061A4 (en) ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRES
DE602008003411D1 (de) Verwendung von d-ribose zur behandlung von vorhofflimmern
BRPI0605940A2 (pt) sìntese de aminas dissubstituìdas úteis em uma etapa
MXPA02011789A (es) Composicion estabilizada de polimero, que contiene halogeno.
HN2006029085A (es) Compuestos farmaceuticos a base de un inhibidor de transcriptasa reversa y meldonio

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.